-
2 killed, 13 wounded in bus blast near Syrian capital: state media
-
Real Madrid extend Vinicius deal, sign Diomande in title bid boost
-
All Blacks skipper Taylor cautiously recovering from calf strain
-
PSG sign France midfielder Akliouche from Monaco
-
UN chief denounces Russia, Ukraine for civilian deaths
-
CONMEBOL 'expresses concern regarding repeated unilateral actions' by FIFA
-
UEFA turn up the pressure on Infantino and repeat boycott threat
-
Warren coy over whether Fury-Joshua will be in UK or US
-
Rodri approves Barcelona transfer talks with Man City: Barca source to AFP
-
Taiwan blocks key bridge in drill for potential Chinese invasion
-
Venezuela unable to tally missing from cataclysmic quakes
-
Migrant children risk abuse on streets of Ceuta, aid groups warn
-
Le Court sprints to stage six Tour de France Femmes win
-
Oil price shoots up as stocks tread water
-
Doping body says Parker's positive cocaine test caused by nutritionist
-
British Grand Prix stays on MotoGP calendar until 2028
-
UEFA says boycott of World Cups stands despite FIFA backdown on private investment
-
Britain's EasyJet flies into US hands as takeover confirmed
-
Rheinmetall sales keep surging despite cancelled naval frigate project
-
Real Madrid sign Ivory Coast winger Yan Diomande
-
Pogacar teammate Del Toro gets new UAE deal after Tour podium
-
How online disinformation fuelled Ceuta migrant surge
-
Stocks tread water with earnings, tech in focus
-
Forex Expo Dubai Announces Opportunity to Win Up to 150 Grams of Gold This September 2026
-
Inevitable AI Group Raises $6M From Aleph to Launch AI-Native SaaS Companies
-
Suspected Ebola death on boat heading for DR Congo capital
-
Forlan named new Uruguay head coach
-
England selector North not 'hung up' on Stokes absence
-
UEFA chief Ceferin: 'Underdog' leader taking fight to FIFA's Infantino
-
UK Anti-Doping confirm former world champ Parker's ban lifted
-
Salah completes move to Turkey's Trabzonspor
-
French winemakers dread 'smoky taste' after wildfires
-
UK clears Paramount's takeover of Warner Bros
-
Stocks diverge with earnings, tech in focus
-
North Korea fires ballistic missile: South Korea military
-
England recall batsman Lawrence for Pakistan series
-
'Don't have to hide': Thai IDs, legal work give hope to Myanmar refugees
-
Siemens shares plunge on disappointing guidance raise
-
Stocks mixed with tech firms back under pressure
-
New Australia coach Kiss gives Japan starts to Ross, Amatosero
-
How Blundell's old school tactic ended England's 'Bazball' era
-
'Stretch our money': Romanians face highest EU inflation
-
Israel reports troop deaths as Lebanon talks underway in Rome
-
Iran says close to Hormuz plan with Oman, but reopening depends on US
-
Seeds Rybakina, Pegula, Gauff reach third round at WTA Toronto
-
Messi scores twice to set Leagues Cup record in Miami victory
-
Police raid South Korea FA in probe into World Cup coach appointment
-
Asian stocks mostly down with tech firms back under pressure
-
Low water on Germany's Rhine river threatens new blow to economy
-
Back to the future as world champion Springboks host All Blacks
Seven deaths in E.Guinea from Marburg virus, 20 others likely linked: WHO
Seven people have been killed in an outbreak of Marburg virus in Equatorial Guinea, with a further 20 deaths "probably" due to the hemorrhagic fever, the World Health Organization said Thursday.
The outbreak of the virus, which is almost as deadly as Ebola, has now spread beyond the province of Kie-Ntem, where it caused the first known deaths in January.
It has reached Bata, the economic capital of the small central African country, according to the government.
The spread of Marburg "is a critical signal to scale up response efforts to quickly stop the chain of transmission and avert a potential large-scale outbreak and loss of life," said Dr Matshidiso Moeti, the WHO's regional director for Africa.
Since the start of the outbreak, "there have been a total of nine laboratory-confirmed cases and 20 probable cases", the WHO said in a report on its website.
"Of the nine laboratory-confirmed cases, seven people have died and all probable cases have died."
Among the 20 probable cases, the patients had all the symptoms of the disease and had been in contact with confirmed cases, but samples could not be taken from their bodies, or they could not be treated, a WHO official told AFP Thursday.
The new cases have been reported from Kie-Ntem in the east, Litoral in the west and the Centro Sur provinces, all of which have borders with Cameroon and Gabon.
The epidemic is therefore now a serious problem in three of Equatorial Guinea's four mainland provinces.
- 'High alert' -
In eastern Africa, Tanzania said Tuesday that five people had died from the virus, while neighbouring Uganda, which had its last outbreak in 2017, said it was on "high alert".
The WHO said additional experts in epidemiology, logistics, health operations and infection prevention and control would be deployed in the coming days.
The agency is also supporting the health authorities in neighbouring Cameroon and Gabon to ramp up outbreak readiness and response capabilities.
The Marburg virus causes severe fever, often accompanied by bleeding and organ failure.
It is part of the so-called filovirus family that also includes Ebola, which has wreaked havoc in several previous outbreaks in Africa.
The suspected natural source of the Marburg virus is the African fruit bat, which carries the pathogen but does not fall sick from it.
The virus takes its name from the German city of Marburg, where it was first identified in 1967, in a lab where workers had been in contact with infected green monkeys imported from Uganda.
The animals can pass the virus to primates in close proximity, including humans, and human-to-human transmission then occurs through contact with blood or other body fluids.
Fatality rates in confirmed cases have ranged from 24 percent to 88 percent in previous outbreaks, depending on the virus strain and case management, according to WHO.
There are currently no vaccines or antiviral treatments, but potential treatments, including blood products, immune therapies and drug therapies, as well as early candidate vaccines, are being evaluated, the WHO says.
R.Veloso--PC